<DOC>
	<DOCNO>NCT00314340</DOCNO>
	<brief_summary>Characterize relative abuse liability short versus long act opioid chronic pain patient .</brief_summary>
	<brief_title>A Comparison Addiction Liability Hydrocodone Sustained Release Morphine</brief_title>
	<detailed_description>A placebo-controlled , double-blind , crossover trial conduct provide study subject either hydrocodone/acetaminophen 30mg/975mg , sustain release morphine 45mg placebo separate GCRC visit . A long acting comparator ( slow-release morphine sulfate 45 mg ) choose putative equianalgesic effect dose hydrocodone ( 30 mg ) select . Subjects participate three session UC Davis/Mather Medical Center General Clinical Research Center ( GCRC ) intervals 7-10 day . Sessions approximately 360 min duration . Subjects receive either hydrocodone/acetaminophen sustain release morphine around-the-clock 7-10 day prior experimental session . At experimental session , assessment abuse liability complete intake medication , well 0 , 60 , 120 , 180 , 240 minute ingestion study medication .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<criteria>Patients chronic pain period great 6 month Patients take great 80 mg morphine equivalent short act opioid ( &gt; 8 vicodin 4 oxycodone/day ) Referral Pain Substance Abuse Clinic selfescalation opioids Inability understand comprehend spoken English Patients Munchausen 's syndrome Patient history Peripheral Vascular Disease Patient history Raynaud 's Phenomenon Liver Disease ; Child 's classification great 1 ( liver cirrhosis ) exclude Renal disease ( BUN &gt; 25 Cr &gt; 1.5 ) Congestive Heart Failure ; Subjects New York Heart Association ( NYHA ) Heart Failure Symptom Classification System Level Impairment II , III IV exclude Coronary artery disease ; recent MI within past six month recent history angina control NTG within past six month Hypertension ; 1 ) previously normotensive subject ; systolic bp &gt; 140 mm Hg diastolic bp &gt; 90 mm Hg 2 ) Hx active treatment antihypertensive medication ; systolic bp &gt; 150 mm Hg diastolic bp &gt; 100 mm Hg Cerebrovascular disease ; recent history within past year transient ischemic attack recent history within past year cerebrovascular event Malignancy require active treatment Patient pregnant ( ascertained selfreport mandatory commercial pregnancy test study medication consume )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Chronic Pain</keyword>
	<keyword>Opioids</keyword>
</DOC>